| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Christopher P. Stewart is Chief Financial Officer at BNGO, with reported holdings spanning 2 companies. Christopher P. Stewart's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $846K at current prices.
Christopher P. Stewart's largest disclosed position is in ALMU as Chief Financial Officer, worth about $508K.
Christopher P. Stewart has 11 Form 4 filings on record from September 2020 to September 2026, across 2 companies: Chief Financial Officer at Aeluma (ALMU), 2026; Chief Financial Officer at Bionano Genomics (BNGO), 2020–2023.
The 16 reported transactions were 6 option or other derivative awards, 4 stock awards, 3 option exercises and 2 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $33K and no sales.
The only open-market purchase was 50,000 shares of BNGO at an average $0.67 on May 12, 2023, about $33K. Twelve months later BNGO was down 86%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2023 | BNGO Bionano Genomics, Inc. | Chief Financial Officer | Buy | 50,000 | $0.67 | $33,415.00 | +21.6% | -39.5% | -85.6% |